Evidence map›Paper›PMID 37485378›Full record

ArticleiScience2023

Total serum

Gabriane Nascimento Porcino, Marco René Bladergroen, Viktoria Dotz, Simone Nicolardi, Elham Memarian, Luiz Gustavo Gardinassi, Carlos Henrique Nery Costa, Roque Pacheco de Almeida, Isabel Kinney Ferreira de Miranda Santos, Manfred Wuhrer

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in iScience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Total plasmaiScience · 2024
    Article
  2. The Human BloodJACS Au · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Gabriane Nascimento PorcinoDepartamento de Bioquímica e Imunologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto 14049-900, Brazil.
Marco René BladergroenCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden 2333 ZA, the Netherlands.
Viktoria DotzCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden 2333 ZA, the Netherlands.
Simone NicolardiCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden 2333 ZA, the Netherlands.
Elham MemarianCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden 2333 ZA, the Netherlands.
Luiz Gustavo GardinassiInstituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia 74605-050, Brazil.
Carlos Henrique Nery CostaInstituto de Doenças Tropicais Natan Portela, Universidade Federal do Piauí, Teresina 64002-510, Brazil.
Roque Pacheco de AlmeidaDepartamento de Medicina, Programa de Pós-Graduação em Ciências da Saúde - PPGCS, Universidade Federal de Sergipe, Aracajú 49060-100, Brazil.
Isabel Kinney Ferreira de Miranda SantosDepartamento de Bioquímica e Imunologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto 14049-900, Brazil.
Manfred WuhrerCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden 2333 ZA, the Netherlands.
Leiden University Medical Center · NLUniversidade de Ribeirão Preto · BRUniversidade Federal de Goiás · BRUniversidade Federal de Sergipe · BRUniversidade Federal do Piauí · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Visceral leishmaniasis (VL) is a clinical form of leishmaniasis with high mortality rates when not treated. Diagnosis suffers from invasive techniques and sub-optimal sensitivities. The current (affordable) treatment with pentavalent antimony as advised by the WHO is possibly harmful to the patient. There is need for an improved diagnosis to prevent possibly unnecessary treatment.

Indexed as

GlycobiologyGlycomicsPathophysiology

Identifiers

PMID37485378
PMCPMC10362369
OpenAlexW4379467539

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.